Initially, m6A modification of PTEN was assessed in glioma cells by MeRIP assay, which identified the presence of m6A modification in PTEN in glioma cells, that is, the expression of PTEN was regulated by m6A modification (Figure 6A). This evidence concerns the gene PTEN and central nervous system cancer.